• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环磷酰胺治疗后暴发性致命性心脏毒性。

Fulminant fatal cardiotoxicity following cyclophosphamide therapy.

机构信息

Department of Cardiology, Institute of Biomedical Research and Innovation, 2-2 Minatojima Minamimachi Chuoku, Kobe 650-0047, Japan.

出版信息

J Cardiol. 2009 Oct;54(2):330-4. doi: 10.1016/j.jjcc.2009.01.006. Epub 2009 Feb 20.

DOI:10.1016/j.jjcc.2009.01.006
PMID:19782276
Abstract

A 59-year-old male with an abdominal mass that showed a diffuse large B cell lymphoma underwent extirpation of the tumor and chemotherapy. He subsequently received high-dose chemotherapy containing cyclophosphamide (1.5 g/m(2)/day x 2 days), followed by autologous peripheral blood stem cell transplantation. He developed congestive heart failure 5 days after administration of cyclophosphamide. His electrocardiogram showed extremely low voltage with ST segment change and echocardiogram showed diffusely increased left ventricular wall thickness, an increase in myocardial echogenicity, pericardial effusion, and generally decreased systolic function. Congestive heart failure progressed rapidly and he died the following day. Post-mortem examination of the heart revealed myocardial hemorrhage, yellowish brown pericardial effusion, and fibrinous pericarditis. His liver was atrophic and focal necrosis was observed histologically. Cyclophosphamide-induced cardiotoxicity occurred, even though the patient had both shown normal cardiac function before high-dose chemotherapy and had received a lower dose of cyclophosphamide. Concomitant administration of cytarabine might have affected his liver function and there might have been interaction between the drugs.

摘要

一位 59 岁男性因腹部肿块被诊断为弥漫性大 B 细胞淋巴瘤,接受了肿瘤切除术和化疗。随后,他接受了含有环磷酰胺(1.5 g/m(2)/天 x 2 天)的大剂量化疗,随后进行了自体外周血干细胞移植。环磷酰胺给药后 5 天出现充血性心力衰竭。他的心电图显示极低电压伴有 ST 段改变,超声心动图显示弥漫性左心室壁增厚,心肌回声增强,心包积液,收缩功能普遍降低。充血性心力衰竭迅速进展,次日死亡。心脏尸检显示心肌出血、黄褐色心包积液和纤维性心包炎。他的肝脏萎缩,组织学观察到局灶性坏死。尽管该患者在大剂量化疗前表现出正常的心脏功能,并接受了较低剂量的环磷酰胺,但仍发生了环磷酰胺诱导的心脏毒性。阿糖胞苷的联合给药可能影响了他的肝功能,并且药物之间可能存在相互作用。

相似文献

1
Fulminant fatal cardiotoxicity following cyclophosphamide therapy.环磷酰胺治疗后暴发性致命性心脏毒性。
J Cardiol. 2009 Oct;54(2):330-4. doi: 10.1016/j.jjcc.2009.01.006. Epub 2009 Feb 20.
2
Cardiotoxicity associated with high-dose cyclophosphamide therapy.与大剂量环磷酰胺治疗相关的心脏毒性。
Arch Intern Med. 1981 May;141(6):758-63.
3
Cyclophosphamide cardiotoxicity in bone marrow transplantation: a prospective evaluation of new dosing regimens.骨髓移植中环磷酰胺的心脏毒性:新给药方案的前瞻性评估。
J Clin Oncol. 1991 Jul;9(7):1215-23. doi: 10.1200/JCO.1991.9.7.1215.
4
Cardiac effects within 3 months of BEAC high-dose therapy in non-Hodgkin's lymphoma patients undergoing autologous stem cell transplantation.接受自体干细胞移植的非霍奇金淋巴瘤患者在BEAC高剂量治疗3个月内的心脏影响。
Eur J Haematol. 2006 Aug;77(2):120-7. doi: 10.1111/j.1600-0609.2006.00687.x.
5
Cyclophosphamide-induced cardiotoxicity with a prolonged clinical course diagnosed on an endomyocardial biopsy.
Intern Med. 2013;52(20):2311-5. doi: 10.2169/internalmedicine.52.0347.
6
[Myocardial hemorrhage due to high-dose cyclophosphamide treatment in a case of non-Hodgkin's lymphoma].
Rinsho Ketsueki. 1993 Mar;34(3):373-7.
7
Cardiotoxicity following cyclophosphamidetherapy: a case report.环磷酰胺治疗后的心脏毒性:一例报告。
J Med Case Rep. 2014 Jul 14;8:252. doi: 10.1186/1752-1947-8-252.
8
High-dose infusional doxorubicin and cyclophosphamide: a feasibility study of tandem high-dose chemotherapy cycles without stem cell support.大剂量输注阿霉素和环磷酰胺:无干细胞支持的串联大剂量化疗周期可行性研究。
Clin Cancer Res. 1997 Dec;3(12 Pt 1):2337-45.
9
High-dose chemotherapy with BEAC regimen and autologous bone marrow transplantation for intermediate grade and immunoblastic lymphoma: durable complete remissions, but a high rate of regimen-related toxicity.采用BEAC方案的大剂量化疗及自体骨髓移植治疗中级别和免疫母细胞淋巴瘤:持久完全缓解,但方案相关毒性发生率高。
Bone Marrow Transplant. 1995 Apr;15(4):549-55.
10
[Primary cardiac lymphoma: cytological diagnosis and treatment with response to polychemotherapy and hematopoietic precursor autotransplant. Presentation of a case a review of the literature].[原发性心脏淋巴瘤:细胞诊断及多药化疗与造血前体自体移植治疗反应。病例报告及文献综述]
An Med Interna. 2002 Jun;19(6):305-9.

引用本文的文献

1
Post-transplant cyclophosphamide-induced cardiotoxicity: A comprehensive review.移植后环磷酰胺诱导的心脏毒性:综述
J Cardiovasc Thorac Res. 2024;16(4):211-221. doi: 10.34172/jcvtr.33230. Epub 2024 Dec 23.
2
Multimodality Imaging of Acute Myocarditis in Cytokine Release Syndrome (CRS) Following CAR-T Therapy.嵌合抗原受体T细胞(CAR-T)治疗后细胞因子释放综合征(CRS)中急性心肌炎的多模态成像
CJC Open. 2024 Apr 17;6(8):973-977. doi: 10.1016/j.cjco.2024.04.004. eCollection 2024 Aug.
3
Association between global longitudinal strain and occurrence of cardiovascular events among pediatric patients following high-dose cyclophosphamide chemotherapy: a prospective cohort study.
高剂量环磷酰胺化疗后儿科患者的整体纵向应变与心血管事件发生之间的关联:一项前瞻性队列研究
Transl Pediatr. 2024 Jul 31;13(7):1061-1070. doi: 10.21037/tp-24-119. Epub 2024 Jul 24.
4
Revisiting treatment-related cardiotoxicity in patients with malignant lymphoma-a review and prospects for the future.恶性淋巴瘤患者治疗相关心脏毒性的再探讨——综述与未来展望
Front Cardiovasc Med. 2023 Aug 30;10:1243531. doi: 10.3389/fcvm.2023.1243531. eCollection 2023.
5
Clinical features and outcomes of patients admitted to the ICU for Cyclophosphamide-associated cardiac toxicity: a retrospective cohort.因环磷酰胺相关心脏毒性而入住 ICU 的患者的临床特征和结局:一项回顾性队列研究。
Support Care Cancer. 2023 Jul 18;31(8):474. doi: 10.1007/s00520-023-07951-9.
6
Cardio-Oncology: Mechanisms, Drug Combinations, and Reverse Cardio-Oncology.心脏肿瘤学:机制、药物组合与逆向心脏肿瘤学。
Int J Mol Sci. 2022 Sep 13;23(18):10617. doi: 10.3390/ijms231810617.
7
Complete Regression of Primary Cardiac Lymphoma With Dose-Attenuated R-CVP Chemotherapeutic Regimen.采用剂量减毒的R-CVP化疗方案使原发性心脏淋巴瘤完全消退
JACC Case Rep. 2019 Sep 4;1(3):332-336. doi: 10.1016/j.jaccas.2019.06.033. eCollection 2019 Oct.
8
Adjuvant breast cancer treatments cardiotoxicity and modern methods of detection and prevention of cardiac complications.辅助乳腺癌治疗的心脏毒性以及心脏并发症的现代检测和预防方法。
ESC Heart Fail. 2021 Aug;8(4):2397-2418. doi: 10.1002/ehf2.13365. Epub 2021 May 5.
9
Breast Radiotherapy-Related Cardiotoxicity. When, How, Why. Risk Prevention and Control Strategies.乳腺癌放疗相关心脏毒性。何时、如何、为何。风险预防与控制策略。
Cancers (Basel). 2021 Apr 4;13(7):1712. doi: 10.3390/cancers13071712.
10
Protective effects of curcumin on chemical and drug-induced cardiotoxicity: a review.姜黄素对化学及药物诱导的心脏毒性的保护作用:综述
Naunyn Schmiedebergs Arch Pharmacol. 2021 Jul;394(7):1341-1353. doi: 10.1007/s00210-021-02072-8. Epub 2021 Mar 5.